Abstract
The benefits of clopidogrel in the treatment and prevention of coronary artery disease vary among patients. Studies have identified predictive markers of poor response to clopidogrel that might allow risk stratification of patients. are we ready to enter the age of personalized medicine?
| Original language | English |
|---|---|
| Pages (from-to) | 334-336 |
| Number of pages | 3 |
| Journal | Nature Reviews Cardiology |
| Volume | 6 |
| Issue number | 5 |
| DOIs |
|
| State | Published - May 2009 |